Lv, H., He, Y., Nie, C., Chen, B., Xu, W., Wang, J., Zhao, J., Chen, X. (2025). Open-label, single-arm, single-center phase 1b/2 clinical study of fruquintinib combined with trastuzumab and XELOX in the first-line treatment of advanced HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps4203